DOI,IST REx ID,Title of publication
10.1186/1479-5876-11-307,8245,Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients